"Emily Cridland [is] relatively young but comes across as very seasoned in front of counterparties. Very responsive, hardworking, and just [an] all-round pleasant [person] to work with." 

Legal 500 UK 2020

Emily Cridland

London
  • 99 Bishopsgate
  • London EC2M 3XF
  • United Kingdom
 
 

Emily Cridland is an associate in the London office of Latham & Watkins and is a member of the firm’s Corporate Department. She primarily handles cross-border mergers and acquisitions, joint ventures, venture capital, reorganizations, and general corporate matters for clients across a variety of industries. Ms. Cridland trained in Latham's London and Singapore offices, gaining a broad range of experience in corporate, public international law and arbitration, project finance, banking, and restructuring.

Ms. Cridland has spent time working in-house on secondment to Markit Group Limited, advising on the acquisitions of DealHub and CoreOne Technologies, working on an investment into a fund run by Illuminate Financial, and assisting with other general corporate and commercial contract work.

Ms. Cridland’s representative transactions include advising:

  • IHS Markit on its joint venture with PIMCO, Man Property Holdings, State Street, and Microsoft to set up a new technology-led company, HUB, to build a cloud-based operating platform aimed at transforming asset managers’ operations technology
  • Novo Holdings A/S on its acquisition of BBI Group, a leading supplier of products and services to the global diagnostics and life sciences industries
  • Nordic Capital on its acquisition of ADVANZ PHARMA, a London-based pharmaceutical company
  • Eleusis Holdings in its acquisition of Kalypso Treatment Centers, a leading provider of ketamine infusion therapies in the United States
  • Atnahs Pharma on its acquisition of assets related to five hypertension medicine brands from AstraZeneca
  • Sony Pictures Television on its acquisition of Silvergate Media, a company focusing on developing, producing, and licensing children’s animation with offices in both London and New York
  • GlaxoSmithKline on its:
    • Divestment of its Prevacid®24HR business to Perrigo Company
    • Divestment of assets relating to the Bialcol and Cibalgina brands in Italy to Vemedia
    • Divestment of certain North American consumer health assets to Crown Laboratories
    • Divestment of five over-the-counter dermatology brands and one pediatric cough remedy brand to the STADA Group
  • Peloton Advantage, a portfolio company of Amulet Capital Partners, in the acquisition of Open Health Communications, a UK-based provider of healthcare communications and market access services
  • Netflix on the acquisition of Millarworld, the comic book company founded by Mark Millar, creator of a number of iconic characters and stories, including Kick-Ass, Kingsman, and Old Man Logan, the first ever acquisition by Netflix
  • ACCO Brands Corporation in connection with its €296.9 million acquisition of Esselte Group, a leading European office products company, from private equity firm J.W. Childs
  • Astorg Partners on its acquisition of Audiotonix, a global producer of audio mixing consoles
 
 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.